Impact of COVID 19 Infection and Development of Cardiovascular Disease
Hongyang Shu(Gangneung–Wonju National University), Dao Wen Wang(Tongji Hospital), Ning Zhou(Tongji Hospital), Zixuan Zhang(Sichuan University), Na Li(China University of Mining and Technology), Wen Zheng(Unknown), Yizhong Peng(Union Hospital), Bala Musa Ceesay(Tongji Hospital)
Cited by 0
Related Papers
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
|Circulation|2018|633
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
|Science China Life Sciences|2020|176
Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases
|Science China Life Sciences|2020|159